<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:podcast="https://podcastindex.org/namespace/1.0" xmlns:media="http://search.yahoo.com/mrss/" version="2.0"><channel><title>RBDCOV Talks</title><link>https://www.spreaker.com/podcast/rbdcov-talks--6016467</link><description><![CDATA[RBDCOV Talks is a ten-episode series where RBDCOV's leading scientists, researchers, medical professionals and community advocates will take us on a knowledge-packed journey to explore and discuss the world of vaccine clinical trials. In these episodes, we will understand how vaccine clinical trials work and talk through interesting topics such as inclusion criteria in a vaccine clinical trial, personalised vaccines and what exactly immunological memory is.]]></description><atom:link href="https://www.spreaker.com/show/6016467/episodes/feed" rel="self" type="application/rss+xml"/><language>en</language><category>Medicine</category><copyright>RBDCOV</copyright><image><url>https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/4d381eddd69fae82db5b2e66d9c48188.jpg</url><title>RBDCOV Talks</title><link>https://www.spreaker.com/podcast/rbdcov-talks--6016467</link></image><lastBuildDate>Tue, 26 Aug 2025 08:06:11 +0000</lastBuildDate><itunes:author>RBDCOV</itunes:author><itunes:owner><itunes:name>RBDCOV</itunes:name><itunes:email>rbdcoveu@gmail.com</itunes:email></itunes:owner><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/4d381eddd69fae82db5b2e66d9c48188.jpg"/><itunes:subtitle>RBDCOV Talks is a ten-episode series where RBDCOV's leading scientists, researchers, medical professionals and community advocates will take us on a knowledge-packed journey to explore and discuss the world of vaccine clinical trials. In these...</itunes:subtitle><itunes:summary><![CDATA[RBDCOV Talks is a ten-episode series where RBDCOV's leading scientists, researchers, medical professionals and community advocates will take us on a knowledge-packed journey to explore and discuss the world of vaccine clinical trials. In these episodes, we will understand how vaccine clinical trials work and talk through interesting topics such as inclusion criteria in a vaccine clinical trial, personalised vaccines and what exactly immunological memory is.]]></itunes:summary><itunes:category text="Health &amp; Fitness"><itunes:category text="Medicine"/></itunes:category><itunes:explicit>false</itunes:explicit><podcast:guid>f51f3fd3-093c-5c8b-a68e-548361d49ade</podcast:guid><itunes:type>serial</itunes:type><item><title>In 5 minutes, what is a recombinant protein vaccine?</title><link>https://www.spreaker.com/episode/in-5-minutes-what-is-a-recombinant-protein-vaccine--57751300</link><description><![CDATA[🧬Dive into the world of recombinant protein vaccines in just 10 minutes with Antonio Barreiro from HIPRA. Unveil the science behind this innovative approach to HIPRA’s vaccine development.]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/57751300</guid><pubDate>Tue, 21 Nov 2023 16:58:13 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/57751300/ep1_rbdcov_211123.mp3" length="10283681" type="audio/mpeg"/><itunes:author>RBDCOV</itunes:author><itunes:subtitle>🧬Dive into the world of recombinant protein vaccines in just 10 minutes with Antonio Barreiro from HIPRA. Unveil the science behind this innovative approach to HIPRA’s vaccine development.</itunes:subtitle><itunes:summary><![CDATA[🧬Dive into the world of recombinant protein vaccines in just 10 minutes with Antonio Barreiro from HIPRA. Unveil the science behind this innovative approach to HIPRA’s vaccine development.]]></itunes:summary><itunes:duration>643</itunes:duration><itunes:explicit>false</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/dcd567d072cef60137fc826643bd537f.jpg"/><itunes:episode>1</itunes:episode><itunes:episodeType>full</itunes:episodeType></item><item><title>What’s Drug Safety? What is Drug Safety-level safety monitoring like in vaccine clinical trials?</title><link>https://www.spreaker.com/episode/what-s-drug-safety-what-is-drug-safety-level-safety-monitoring-like-in-vaccine-clinical-trials--57752293</link><description><![CDATA[Discover the critical role of Drug Safety in vaccine trials with Helena Belinchon from ASPHALION. 🩺 How do experts ensure safety at every level? Join the safety journey now! 🌟💊]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/57752293</guid><pubDate>Tue, 21 Nov 2023 17:52:23 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/57752293/ep2_rbdcov_211123.mp3" length="9102900" type="audio/mpeg"/><itunes:author>RBDCOV</itunes:author><itunes:subtitle>Discover the critical role of Drug Safety in vaccine trials with Helena Belinchon from ASPHALION. 🩺 How do experts ensure safety at every level? Join the safety journey now! 🌟💊</itunes:subtitle><itunes:summary><![CDATA[Discover the critical role of Drug Safety in vaccine trials with Helena Belinchon from ASPHALION. 🩺 How do experts ensure safety at every level? Join the safety journey now! 🌟💊]]></itunes:summary><itunes:duration>569</itunes:duration><itunes:explicit>false</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/dcd567d072cef60137fc826643bd537f.jpg"/><itunes:episode>2</itunes:episode><itunes:episodeType>full</itunes:episodeType></item><item><title>All about vaccine clinical trials: what are they and how do they work?</title><link>https://www.spreaker.com/episode/all-about-vaccine-clinical-trials-what-are-they-and-how-do-they-work--57752327</link><description><![CDATA[Explore the intricate world of vaccine clinical trials with Montse Barceló from VERISTAT. 🧪 What are they, and how do they shape the future of healthcare?]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/57752327</guid><pubDate>Tue, 21 Nov 2023 17:55:25 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/57752327/ep3_rbdcov_211123.mp3" length="10705773" type="audio/mpeg"/><itunes:author>RBDCOV</itunes:author><itunes:subtitle>Explore the intricate world of vaccine clinical trials with Montse Barceló from VERISTAT. 🧪 What are they, and how do they shape the future of healthcare?</itunes:subtitle><itunes:summary><![CDATA[Explore the intricate world of vaccine clinical trials with Montse Barceló from VERISTAT. 🧪 What are they, and how do they shape the future of healthcare?]]></itunes:summary><itunes:duration>670</itunes:duration><itunes:explicit>false</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/dcd567d072cef60137fc826643bd537f.jpg"/><itunes:episode>3</itunes:episode><itunes:episodeType>full</itunes:episodeType></item><item><title>All about immunological memory: what is it, how is it obtained and what is the result?</title><link>https://www.spreaker.com/episode/all-about-immunological-memory-what-is-it-how-is-it-obtained-and-what-is-the-result--57752353</link><description><![CDATA[Unveil the vital role of immunological memory, the key to long-lasting, protective immunity with Pere Soler Palacin from Vall D'Hebron. Understand why vaccinations earn immense respect in the scientific community for bolstering our defenses against infectious diseases. 🌐💪]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/57752353</guid><pubDate>Tue, 21 Nov 2023 17:59:39 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/57752353/ep4_rbdcov_211123.mp3" length="5630128" type="audio/mpeg"/><itunes:author>RBDCOV</itunes:author><itunes:subtitle>Unveil the vital role of immunological memory, the key to long-lasting, protective immunity with Pere Soler Palacin from Vall D'Hebron. Understand why vaccinations earn immense respect in the scientific community for bolstering our defenses against...</itunes:subtitle><itunes:summary><![CDATA[Unveil the vital role of immunological memory, the key to long-lasting, protective immunity with Pere Soler Palacin from Vall D'Hebron. Understand why vaccinations earn immense respect in the scientific community for bolstering our defenses against infectious diseases. 🌐💪]]></itunes:summary><itunes:duration>352</itunes:duration><itunes:explicit>false</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/dcd567d072cef60137fc826643bd537f.jpg"/><itunes:episode>4</itunes:episode><itunes:episodeType>full</itunes:episodeType></item><item><title>Why have paediatric and adolescent participants been included in this trial?</title><link>https://www.spreaker.com/episode/why-have-paediatric-and-adolescent-participants-been-included-in-this-trial--57752386</link><description><![CDATA[Explore the significance of including the youngest in vaccine trials with Pablo Rojo from PENTA. Join us as we discuss the impact on child health and the broader community. 🌍💉]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/57752386</guid><pubDate>Tue, 21 Nov 2023 18:01:53 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/57752386/ep5_rbdcov_211123.mp3" length="7271821" type="audio/mpeg"/><itunes:author>RBDCOV</itunes:author><itunes:subtitle>Explore the significance of including the youngest in vaccine trials with Pablo Rojo from PENTA. Join us as we discuss the impact on child health and the broader community. 🌍💉</itunes:subtitle><itunes:summary><![CDATA[Explore the significance of including the youngest in vaccine trials with Pablo Rojo from PENTA. Join us as we discuss the impact on child health and the broader community. 🌍💉]]></itunes:summary><itunes:duration>455</itunes:duration><itunes:explicit>false</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/dcd567d072cef60137fc826643bd537f.jpg"/><itunes:episode>5</itunes:episode><itunes:episodeType>full</itunes:episodeType></item><item><title>Why should people living with HIV and other immunocompromising conditions be included in clinical trials similar to the RBDCOV trial?</title><link>https://www.spreaker.com/episode/why-should-people-living-with-hiv-and-other-immunocompromising-conditions-be-included-in-clinical-trials-similar-to-the-rbdcov-trial--57752394</link><description><![CDATA[Shed light on immunocompromised clinical trials inclusion. 🦠 Why involve those with HIV? <br />Join our conversation with Juanfran C and Arda from EATG to understand better the significance for a more inclusive and effective future.]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/57752394</guid><pubDate>Tue, 21 Nov 2023 18:09:42 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/57752394/ep6_rbdcov_211123.mp3" length="7972739" type="audio/mpeg"/><itunes:author>RBDCOV</itunes:author><itunes:subtitle>Shed light on immunocompromised clinical trials inclusion. 🦠 Why involve those with HIV? 
Join our conversation with Juanfran C and Arda from EATG to understand better the significance for a more inclusive and effective future.</itunes:subtitle><itunes:summary><![CDATA[Shed light on immunocompromised clinical trials inclusion. 🦠 Why involve those with HIV? <br />Join our conversation with Juanfran C and Arda from EATG to understand better the significance for a more inclusive and effective future.]]></itunes:summary><itunes:duration>499</itunes:duration><itunes:explicit>false</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/dcd567d072cef60137fc826643bd537f.jpg"/><itunes:episode>6</itunes:episode><itunes:episodeType>full</itunes:episodeType></item><item><title>All about personalised vaccines: what are they and what is their future?</title><link>https://www.spreaker.com/episode/all-about-personalised-vaccines-what-are-they-and-what-is-their-future--57752480</link><description><![CDATA[Delves into personalized vaccines. What makes them unique, and what does the future hold for customized immunization? Uncover its potential with Julia García-Prado from IrsiCaixa! 🚀🔍]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/57752480</guid><pubDate>Tue, 21 Nov 2023 18:12:03 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/57752480/ep7_rbdcov_211123.mp3" length="8137833" type="audio/mpeg"/><itunes:author>RBDCOV</itunes:author><itunes:subtitle>Delves into personalized vaccines. What makes them unique, and what does the future hold for customized immunization? Uncover its potential with Julia García-Prado from IrsiCaixa! 🚀🔍</itunes:subtitle><itunes:summary><![CDATA[Delves into personalized vaccines. What makes them unique, and what does the future hold for customized immunization? Uncover its potential with Julia García-Prado from IrsiCaixa! 🚀🔍]]></itunes:summary><itunes:duration>509</itunes:duration><itunes:explicit>false</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/dcd567d072cef60137fc826643bd537f.jpg"/><itunes:episode>7</itunes:episode><itunes:episodeType>full</itunes:episodeType></item><item><title>Where are we with COVID-19 and what does the future hold?</title><link>https://www.spreaker.com/episode/where-are-we-with-covid-19-and-what-does-the-future-hold--57752491</link><description><![CDATA[Considering how changing the COVID situation is, let's understand where we are with COVID-19 and what the future holds with Dr. Mete Tam from METPHARM.]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/57752491</guid><pubDate>Tue, 21 Nov 2023 18:14:00 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/57752491/ep8_rbdcov_211123.mp3" length="11045993" type="audio/mpeg"/><itunes:author>RBDCOV</itunes:author><itunes:subtitle>Considering how changing the COVID situation is, let's understand where we are with COVID-19 and what the future holds with Dr. Mete Tam from METPHARM.</itunes:subtitle><itunes:summary><![CDATA[Considering how changing the COVID situation is, let's understand where we are with COVID-19 and what the future holds with Dr. Mete Tam from METPHARM.]]></itunes:summary><itunes:duration>691</itunes:duration><itunes:explicit>false</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/dcd567d072cef60137fc826643bd537f.jpg"/><itunes:episode>8</itunes:episode><itunes:episodeType>full</itunes:episodeType></item><item><title>What will the direct contribution of RBDCOV be if both clinical trials are proven to be effective?</title><link>https://www.spreaker.com/episode/what-will-the-direct-contribution-of-rbdcov-be-if-both-clinical-trials-are-proven-to-be-effective--57752507</link><description><![CDATA[In this episode, we decode RBDCOV's direct contribution. What if both trials succeed? Let's understand the potential impact on global health with Dr. Antoni Castro from IDIBGI🌐💉]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/57752507</guid><pubDate>Tue, 21 Nov 2023 18:15:25 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/57752507/ep9_rbdcov_211123.mp3" length="5726208" type="audio/mpeg"/><itunes:author>RBDCOV</itunes:author><itunes:subtitle>In this episode, we decode RBDCOV's direct contribution. What if both trials succeed? Let's understand the potential impact on global health with Dr. Antoni Castro from IDIBGI🌐💉</itunes:subtitle><itunes:summary><![CDATA[In this episode, we decode RBDCOV's direct contribution. What if both trials succeed? Let's understand the potential impact on global health with Dr. Antoni Castro from IDIBGI🌐💉]]></itunes:summary><itunes:duration>358</itunes:duration><itunes:explicit>false</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/dcd567d072cef60137fc826643bd537f.jpg"/><itunes:episode>9</itunes:episode><itunes:episodeType>full</itunes:episodeType></item><item><title>Trial results: what are they main findings and what’s next?</title><link>https://www.spreaker.com/episode/trial-results-what-are-they-main-findings-and-what-s-next--57752521</link><description><![CDATA[Why is data so crucial? Is it only significant for the scientific community? Let's address the importance of collaboration and data sharing for a health project with Laura Sesma from Zabala Innovation.]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/57752521</guid><pubDate>Tue, 21 Nov 2023 18:16:29 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/57752521/ep10_rbdcov_211123.mp3" length="7237131" type="audio/mpeg"/><itunes:author>RBDCOV</itunes:author><itunes:subtitle>Why is data so crucial? Is it only significant for the scientific community? Let's address the importance of collaboration and data sharing for a health project with Laura Sesma from Zabala Innovation.</itunes:subtitle><itunes:summary><![CDATA[Why is data so crucial? Is it only significant for the scientific community? Let's address the importance of collaboration and data sharing for a health project with Laura Sesma from Zabala Innovation.]]></itunes:summary><itunes:duration>453</itunes:duration><itunes:explicit>false</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/dcd567d072cef60137fc826643bd537f.jpg"/><itunes:episode>10</itunes:episode><itunes:episodeType>full</itunes:episodeType></item><item><title>It Starts and Ends With Us: Community at the Centre of Research.</title><link>https://www.spreaker.com/episode/it-starts-and-ends-with-us-community-at-the-centre-of-research--67515158</link><description><![CDATA[How the community engagement campaign was built and why inclusion and diversity in clinical research are more than buzzwords they’re essential for impact? Let’s take a closer look with Tania Sanchis and Apostolos Kalogiannis from EATG, as they share insights about the campaign.]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/67515158</guid><pubDate>Tue, 26 Aug 2025 06:51:12 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/67515158/ep11_rbdcov_040825.mp3" length="11743080" type="audio/mpeg"/><itunes:author>RBDCOV</itunes:author><itunes:subtitle>How the community engagement campaign was built and why inclusion and diversity in clinical research are more than buzzwords they’re essential for impact? Let’s take a closer look with Tania Sanchis and Apostolos Kalogiannis from EATG, as they share...</itunes:subtitle><itunes:summary><![CDATA[How the community engagement campaign was built and why inclusion and diversity in clinical research are more than buzzwords they’re essential for impact? Let’s take a closer look with Tania Sanchis and Apostolos Kalogiannis from EATG, as they share insights about the campaign.]]></itunes:summary><itunes:duration>482</itunes:duration><itunes:explicit>false</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/4d381eddd69fae82db5b2e66d9c48188.jpg"/><itunes:episode>11</itunes:episode><itunes:episodeType>full</itunes:episodeType></item><item><title>The Psychosocial Perspective: what participants teach us.</title><link>https://www.spreaker.com/episode/the-psychosocial-perspective-what-participants-teach-us--67515170</link><description><![CDATA[💬 What motivated participants to join? How did they experience the process? And what lessons can we learn from their stories? Join Daniela Rojas Castro from EATG, who has played a leading role in ensuring that the voices of affected communities are not just heard, but actively shape the direction of the project.]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/67515170</guid><pubDate>Tue, 26 Aug 2025 06:53:41 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/67515170/ep12_rbdcov_040825.mp3" length="15074496" type="audio/mpeg"/><itunes:author>RBDCOV</itunes:author><itunes:subtitle>💬 What motivated participants to join? How did they experience the process? And what lessons can we learn from their stories? Join Daniela Rojas Castro from EATG, who has played a leading role in ensuring that the voices of affected communities are...</itunes:subtitle><itunes:summary><![CDATA[💬 What motivated participants to join? How did they experience the process? And what lessons can we learn from their stories? Join Daniela Rojas Castro from EATG, who has played a leading role in ensuring that the voices of affected communities are not just heard, but actively shape the direction of the project.]]></itunes:summary><itunes:duration>621</itunes:duration><itunes:explicit>false</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/4d381eddd69fae82db5b2e66d9c48188.jpg"/><itunes:episode>12</itunes:episode><itunes:episodeType>full</itunes:episodeType></item><item><title>Lessons Learned: insights, learnings, and takeaways.</title><link>https://www.spreaker.com/episode/lessons-learned-insights-learnings-and-takeaways--67515182</link><description><![CDATA[As RBDCOV nears its end, what have we truly learned? 📚 Laura Ferrer from HIPRA reflects on the key takeaways, lessons, and insights gained throughout the project—from challenges to breakthroughs.]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/67515182</guid><pubDate>Tue, 26 Aug 2025 06:55:43 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/67515182/ep13_rbdcov_080825.mp3" length="20073233" type="audio/mpeg"/><itunes:author>RBDCOV</itunes:author><itunes:subtitle>As RBDCOV nears its end, what have we truly learned? 📚 Laura Ferrer from HIPRA reflects on the key takeaways, lessons, and insights gained throughout the project—from challenges to breakthroughs.</itunes:subtitle><itunes:summary><![CDATA[As RBDCOV nears its end, what have we truly learned? 📚 Laura Ferrer from HIPRA reflects on the key takeaways, lessons, and insights gained throughout the project—from challenges to breakthroughs.]]></itunes:summary><itunes:duration>830</itunes:duration><itunes:explicit>false</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/4d381eddd69fae82db5b2e66d9c48188.jpg"/><itunes:episode>13</itunes:episode><itunes:episodeType>full</itunes:episodeType></item></channel></rss>
